Eris, New COVID variant surfaces in India
The global Covid-19 pandemic, caused by the SARS-CoV-2 virus, continues to impact lives and economies worldwide. New variants of the virus have emerged, with some posing greater risks. It was first detected in India in May 2023. Despite the lack of significant case increases for two subsequent months, the state's health department data now indicates a rise from 70 cases at the end of July to 115 cases as of August 6.
The variant was found in samples from travelers who arrived from South Africa in Bengaluru and Pune, Maharashtra.Eris, initially known as B.1.1.529.27, first surfaced in South Africa in November 2022. It shares lineage with the Beta variant, first detected in South Africa in 2020. The variant is defined by 27 mutations in its spike protein, which is responsible for attaching to human cells and facilitating infection.
Eris boasts a higher estimated reproduction number than Omicron, indicating a potentially faster transmission rate. However it doesn't necessarily correlate with heightened danger. Factors affecting severity include the patient's age, health condition, healthcare quality, preventive measures, and treatments.
While Eris symptoms align with typical Covid-19 indicators, most cases have been mild or asymptomatic.Current vaccines remain effective against Eris, although their efficacy might be slightly reduced due to spike protein mutations.
Prior infection and immunity also provide protection.The variant's subsequent spread to India warrants vigilance, but panic is unwarranted. Although Eris possesses mutations and transmissibility, it lacks confirmed links to heightened severity or vaccine resistance.
We should focus on proactive measures like detecting, monitoring, and containing Eris.
Strengthening vaccination efforts and adhering to Covid-19 protocols are vital steps needed to stay safe.
Report by Shaurya
Graphics by Khushpreet
.png)
Comments